Journal article
Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose to Assess Glycemia in Gestational Diabetes
DP Zaharieva, JH Teng, ML Ong, MH Lee, B Paldus, L Jackson, C Houlihan, A Shub, S Tipnis, O Cohen, DN O'Neal, B Krishnamurthy
Diabetes Technology and Therapeutics | MARY ANN LIEBERT, INC | Published : 2020
Abstract
Background: Gestational diabetes mellitus (GDM) management using self-monitoring blood glucose (SMBG) does not normalize pregnancy outcomes. Objective: We aimed to conduct an observational study to explore if continuous glucose monitoring (CGM) could identify elevated glucose levels not apparent in women with GDM managed using SMBG. Study Design: A 7-day masked-CGM (iPro; Medtronic) was performed within 2 weeks of GDM diagnosis, immediately post-GDM education, but before insulin commencement as determined by SMBG. CGM data regarding hyperglycemia (sensor glucose >126 mg/dL [06:00-00:00 h] and >99 mg/dL [00:00-06:00 h] for >10% of time), time with health care professionals, treatment, and pre..
View full abstractGrants
Funding Acknowledgements
This investigator-initiated study was supported by funds from Mercy Hospitals with material support Medtronic Australasia Pty. Ltd. The funding bodies had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.